Total Payments
$29,489
2024 Payments
$2,793
Companies
40
Transactions
823
Medicare Patients
12,399
Medicare Billing
$838,303
Payment Breakdown by Category
Food & Beverage$15,550 (52.7%)
Consulting$11,925 (40.4%)
Travel$1,068 (3.6%)
Other$500.00 (1.7%)
Education$445.99 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,550 | 805 | 52.7% |
| Consulting Fee | $11,925 | 6 | 40.4% |
| Travel and Lodging | $1,068 | 4 | 3.6% |
| Honoraria | $500.00 | 1 | 1.7% |
| Education | $445.99 | 7 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $12,624 | 180 | $0 (2024) |
| ABBVIE INC. | $3,294 | 92 | $0 (2024) |
| Allergan, Inc. | $1,815 | 9 | $0 (2022) |
| Lilly USA, LLC | $1,554 | 73 | $0 (2024) |
| Janssen Biotech, Inc. | $1,470 | 64 | $0 (2024) |
| PFIZER INC. | $910.52 | 57 | $0 (2024) |
| UCB, Inc. | $824.89 | 40 | $0 (2024) |
| Encore Dermatology Inc. | $641.41 | 5 | $0 (2018) |
| Amgen Inc. | $626.84 | 32 | $0 (2024) |
| Dermavant Sciences, Inc. | $551.85 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,793 | 137 | Janssen Biotech, Inc. ($557.71) |
| 2023 | $3,443 | 127 | ABBVIE INC. ($1,324) |
| 2022 | $2,901 | 95 | ABBVIE INC. ($1,065) |
| 2021 | $7,029 | 95 | Galderma Laboratories, L.P. ($5,609) |
| 2020 | $5,788 | 81 | Galderma Laboratories, L.P. ($4,820) |
| 2019 | $1,425 | 84 | Galderma Laboratories, L.P. ($384.20) |
| 2018 | $2,087 | 86 | Encore Dermatology Inc. ($595.69) |
| 2017 | $4,024 | 118 | Allergan Inc. ($1,729) |
All Payment Transactions
823 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Immunology | ||||||
| 12/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $30.78 | General |
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $70.15 | General |
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Immunology | ||||||
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Immunology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.25 | General |
| Category: Immunology | ||||||
| 10/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Immunology | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.86 | General |
| Category: Immunology | ||||||
| 10/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,207 | 5,086 | $516,892 | $227,510 |
| 2022 | 18 | 3,161 | 4,864 | $493,598 | $219,756 |
| 2021 | 19 | 3,157 | 5,005 | $482,742 | $218,863 |
| 2020 | 20 | 2,874 | 4,368 | $385,149 | $172,175 |
Total Patients
12,399
Total Services
19,323
Medicare Billing
$838,303
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,100 | 1,529 | $219,381 | $99,650 | 45.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 358 | 399 | $64,897 | $30,161 | 46.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 423 | 549 | $59,000 | $23,660 | 40.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 213 | 213 | $38,376 | $15,440 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 265 | 315 | $36,232 | $13,152 | 36.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 140 | 149 | $27,039 | $13,139 | 48.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 277 | 1,250 | $13,108 | $6,553 | 50.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 34 | 50 | $14,383 | $6,120 | 42.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 91 | 143 | $11,535 | $5,993 | 52.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 62 | 89 | $8,167 | $3,276 | 40.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 56 | 56 | $6,455 | $2,841 | 44.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 26 | 27 | $5,457 | $2,684 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 20 | $4,051 | $1,802 | 44.5% |
| 69100 | Biopsy of ear | Office | 2023 | 23 | 25 | $3,898 | $1,590 | 40.8% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 13 | 13 | $1,242 | $650.64 | 52.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 58 | $1,661 | $641.47 | 38.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 85 | 201 | $2,010 | $158.05 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 916 | 1,261 | $184,122 | $85,762 | 46.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 346 | 395 | $66,070 | $31,268 | 47.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 430 | 559 | $61,347 | $25,047 | 40.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 346 | 407 | $48,362 | $17,768 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 202 | 202 | $36,847 | $15,366 | 41.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 132 | 143 | $26,458 | $12,535 | 47.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 41 | 51 | $14,875 | $6,953 | 46.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 287 | 1,177 | $12,714 | $6,279 | 49.4% |
About Dr. Julie Moore, M.D
Dr. Julie Moore, M.D is a Dermatology healthcare provider based in Melrose Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053373589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Moore, M.D has received a total of $29,489 in payments from pharmaceutical and medical device companies, with $2,793 received in 2024. These payments were reported across 823 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($15,550).
As a Medicare-enrolled provider, Moore has provided services to 12,399 Medicare beneficiaries, totaling 19,323 services with total Medicare billing of $838,303. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Melrose Park, IL
- Active Since 04/03/2006
- Last Updated 02/17/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053373589
Products in Payments
- ORACEA (Drug) $5,717
- AKLIEF (Drug) $4,862
- RHOFADE (Drug) $1,659
- TALTZ (Drug) $1,356
- BOTOX (Biological) $1,242
- TREMFYA (Drug) $773.48
- SOOLANTRA (Drug) $685.79
- DUPIXENT (Biological) $631.50
- EPIDUO FORTE (Drug) $598.47
- Impoyz (Drug) $595.69
- Cimzia (Drug) $565.52
- VTAMA (Drug) $551.85
- SKYRIZI (Biological) $544.85
- EUCRISA (Drug) $540.73
- Sotyktu (Drug) $439.65
- COSENTYX (Biological) $437.14
- DORYX (Drug) $374.11
- Enbrel (Biological) $330.48
- Otezla (Drug) $319.17
- Humira (Biological) $296.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.